Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Therapeutics and Clinical Risk Management|July 20, 2017
Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinomaAlessandro Leonetti, Francesco Leonardi, Melissa Bersanelli, et al.
Core Evidence|September 14, 2016
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapySebastiano Buti, Alessandro Leonetti, Alice Dallatomasina, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
Expert Review of Clinical Pharmacology|October 22, 2019
Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'Alessandro Leonetti, Lenka Boyd, Jacopo Giuliani, et al.
Expert Opinion on Pharmacotherapy|April 16, 2020
Is there a role for dacomitinib, a second-generation irreversible inhibitor of the epidermal-growth factor receptor tyrosine kinase, in advanced non-small cell lung cancer?Cecilia Bergonzini, Alessandro Leonetti, Marcello Tiseo, et al.
Cancers|July 27, 2024
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future ChallengesDiego Luigi Cortinovis, Alessandro Leonetti, Alessandro Morabito, et al.
British Journal of Cancer|October 1, 2019
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancerAlessandro Leonetti, Sugandhi Sharma, Roberta Minari, et al.
Expert Review of Anticancer Therapy|June 1, 2019
Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirineRobin Van Den Borg, Alessandro Leonetti, Marcello Tiseo, et al.
Current Treatment Options in Oncology|September 15, 2021
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer ImmunotherapyGiulia Mazzaschi, Alessandro Leonetti, Roberta Minari, et al.
Immunotherapy|November 21, 2022
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinibGiulia Airò, Michele Maffezzoli, Alessandro Lazzarin, et al.
Pageof 7